Small nonconjugative R plasmids conferring resistance to sulfonamide (Su), streptomycin (Sm), and ampicillin (Ap) are relatively common in clinical isolates of enteric bacilli. The prototypes of these plasmids are the Ap(NTP1) and Su Sm(NTP2) plasmids initially described by Anderson and his colleagues (1-3). Smith et al. (16) showed that 19 of 26 Su Sm plasmid species from various Salmonella serotypes belonged to the same compatibility group as did an Su Sm Ap plasmid. Barth and Grinter (4) examined a number of Su Sm plasmids that were representative of a broad host and geographical range. They found that 10 of 12 of these plasmids possessed an identical molecular mass and had many of the same nucleotide sequences. On this basis, it was suggested that a single plasmid evolved once and has spread efficiently with relatively few modifications around the world. The prototype Ap plasmid has been shown to be compatible with, and unrelated to, Su Sm plasmids, but highly related to other Ap plasmids of independent origin (16; Crosa, Matta, Olarte, and Falkow, unpublished observations). Nevertheless, a strain of Salmonella typhimurium carrying an independent AP and Su Sm plasmid produced a single Su Ap plasmid after ultraviolet irradiation; this was interpreted as the insertion of at least a part of the Ap determinant into Su Sm with loss or inactivation of the streptomycin resistance gene (16) .
There is now clear laboratory evidence that the structural gene for ampicillin resistance resides upon a 3.2 x 106-dalton sequence of deoxyribonucleic acid (DNA), TnA, that is capable of transposition from replicon to replicon (5, 10 to 13). Insertion of TnA is mutagenic when it occurs within structural genes and polar when it occurs within an operon (11) . We have shown that TnA from two large conjugative R plasmids, Rldrd-19 and R64-1, can insert in the plasmid RSF1010 (RSF1010 is identical to the prototype Su Sm plasmid of Anderson and Lewis [2, 3] ). TnA insertion can occur at a minimum of 19 distinct sites on the RSF1010 genome (11, 15) . Depending upon the site and orientation of TnA insertion, the phenotype of the recombinant plasmid may be Su Sm Ap; Su Ap; Sm Ap; and Ap only (11, 15 (14) , to determine their molecular nature and their relationship to naturally occurring Su Sm plasmids and TnA-containing RSF1010 plasmids isolated in laboratory experiments. The properties of RSF1010, R645, R870, and other plasmids used in this study are summarized in Table 1. R645 and R860 were isolated as covalently closed circular molecules as described previously (11, 12) and transformed (8) (11) . RSF1010 carrying TnA (recombinant plasmids) were likewis,e uniformly 8.7 x 106 in molecular weight and contained a single EcoRI site (11) . When sedimented together in neutral sucrose gradients, the clinical isolates and laboratory-constructed plasmids precisely cosedimented (Fig. 1) Several theories for the origin of R plasmids and the origin of antibiotic resistance genes have been proposed (6, 7, 17) . The discovery of the transposability of antibiotic resistance genes provides a mechanism by which they might be easily interchanged between replicons and accounts for several long-standing observations about the epidemiology of R plasmids (9, 11) . R plasmid-encoded antibiotic resistance enzymes show, by and large, no relationship to chromosome-encoded enzymes of the enteric bacteria, suggesting that they have not been LITERATURE CITED
